Open-house pharmaceutical discount contracts
Original notice title
Germany – Pharmaceutical products – Arzneimittelrabattverträge gem. § 130a Abs. 8 SGB V im Rahmen von Open-House-Verfahren
Opportunity Score
Why this score?
Opportunity
0 / 100
Complexity
0 / 100
Deep Portfolio Analysis
Uses:
- Description
- Industries & Services
- Capabilities
- Market & Experience
- Certifications
We couldn't generate the AI analysis for this tender. Please try again later.
Buyer
Lots (25)
LOT-0001
Atorvastatin und Ezetimib; Tabletten, Filmtabletten; 90 Stück; ATC-Code: C10BA05
Atorvastatin und Ezetimib; Tabletten, Filmtabletten; 90 Stück; ATC-Code: C10BA05
Location
Duration
Category
Award details
Selection criteria
LOT-0002
Calcipotriol und Betamethason; Creme, Schaum; ATC-Code: D05AX52 (WHO); D05AX22 (ADV)
Calcipotriol und Betamethason; Creme, Schaum; ATC-Code: D05AX52 (WHO); D05AX22 (ADV)
Location
Duration
Category
Award details
Selection criteria
LOT-0003
Calcipotriol; Creme; ATC-Code: D05AX02
Calcipotriol; Creme; ATC-Code: D05AX02
Location
Duration
Category
Award details
Selection criteria
LOT-0004
Cefadroxil; ATC-Code: J01DB05
Cefadroxil; ATC-Code: J01DB05
Location
Duration
Category
Award details
Selection criteria
LOT-0005
Clobazam; ATC-Code: N05BA09
Clobazam; ATC-Code: N05BA09
Location
Duration
Category
Award details
Selection criteria
LOT-0006
Dienogest und Estradiol; ATC-Code: G03AB08
Dienogest und Estradiol; ATC-Code: G03AB08
Location
Duration
Category
Award details
Selection criteria
LOT-0007
Distigmin; ATC-Code: N07AA03
Distigmin; ATC-Code: N07AA03
Location
Duration
Category
Award details
Selection criteria
LOT-0008
Dolutegravir; ATC-Code: J05AJ03
Dolutegravir; ATC-Code: J05AJ03
Location
Duration
Category
Award details
Selection criteria
LOT-0009
Eisen(II)sulfat; Retardtabletten; ATC-Code: B03AA07
Eisen(II)sulfat; Retardtabletten; ATC-Code: B03AA07
Location
Duration
Category
Award details
Selection criteria
LOT-0010
Emtricitabin, Tenofovirdisoproxil und Rilpivirin; ATC-Code: J05AR08
Emtricitabin, Tenofovirdisoproxil und Rilpivirin; ATC-Code: J05AR08
Location
Duration
Category
Award details
Selection criteria
LOT-0011
Fondaparinux; ATC-Code: B01AX05
Fondaparinux; ATC-Code: B01AX05
Location
Duration
Category
Award details
Selection criteria
LOT-0012
Fusidinsäure, Natriumsalz; ATC-Code: D06AX01
Fusidinsäure, Natriumsalz; ATC-Code: D06AX01
Location
Duration
Category
Award details
Selection criteria
LOT-0013
Granisetron; Pflaster transdermal; ATC-Code: A04AA02
Granisetron; Pflaster transdermal; ATC-Code: A04AA02
Location
Duration
Category
Award details
Selection criteria
LOT-0014
Levetiracetam; Wirkstärke 1500 mg; ATC-Code: N03AX14
Levetiracetam; Wirkstärke 1500 mg; ATC-Code: N03AX14
Location
Duration
Category
Award details
Selection criteria
LOT-0015
Midazolam; Fertigspritzen; ATC-Code: N05CD08 (WHO); N03AE02 (ADV)
Midazolam; Fertigspritzen; ATC-Code: N05CD08 (WHO); N03AE02 (ADV)
Location
Duration
Category
Award details
Selection criteria
LOT-0016
Olanzapin; Trockensubstanz mit Lösungsmittel; ATC-Code: N05AH03
Olanzapin; Trockensubstanz mit Lösungsmittel; ATC-Code: N05AH03
Location
Duration
Category
Award details
Selection criteria
LOT-0017
Oxybutynin; Lösung zur intravesikalen Anwendung; ATC-Code: G04BD04
Oxybutynin; Lösung zur intravesikalen Anwendung; ATC-Code: G04BD04
Location
Duration
Category
Award details
Selection criteria
LOT-0018
Oxycodon und Naloxon, 60mg/30mg und 80mg/40mg; ATC-Code: N02AA55
Oxycodon und Naloxon, 60mg/30mg und 80mg/40mg; ATC-Code: N02AA55
Location
Duration
Category
Award details
Selection criteria
LOT-0019
Pimecrolimus; ATC-Code: D11AH02
Pimecrolimus; ATC-Code: D11AH02
Location
Duration
Category
Award details
Selection criteria
LOT-0020
Pyridostigmin; überzogene Tabletten; ATC-Code: N07AA02
Pyridostigmin; überzogene Tabletten; ATC-Code: N07AA02
Location
Duration
Category
Award details
Selection criteria
LOT-0021
Sofosbuvir, Velpatasvir und Voxilaprevir; ATC-Code: J05AP56
Sofosbuvir, Velpatasvir und Voxilaprevir; ATC-Code: J05AP56
Location
Duration
Category
Award details
Selection criteria
LOT-0022
Tacrolimus; 0,1 %; Salbe; ATC-Code: D11AH01
Tacrolimus; 0,1 %; Salbe; ATC-Code: D11AH01
Location
Duration
Category
Award details
Selection criteria
LOT-0023
Trientin; Wirkstärke 167 mg; ATC-Code: A16AX12
Trientin; Wirkstärke 167 mg; ATC-Code: A16AX12
Location
Duration
Category
Award details
Selection criteria
LOT-0024
Ustekinumab; ATC-Code: L04AC05
Ustekinumab; ATC-Code: L04AC05
Location
Duration
Category
Award details
Selection criteria
LOT-0025
Aflibercept; 40 mg/ml; ATC-Code: S01LA05
Aflibercept; 40 mg/ml; ATC-Code: S01LA05
Location
Duration
Category
Award details
Selection criteria
Procurement Details
- Publication date
- 23 Oct 2025
- Notice type
- Contract notice — standard
- Languages
- German
Reference metadata
- Notice subtype
- 16
- Notice version
- 1
- Legal basis
- 32014L0024
Reference IDs
- Tender ID
- 702716-2025
Documents (1)
Similar tenders
Germany – Heating, ventilation and air-conditioning installation work – VE BT11-4310-01 Lüftung
Belgium – Electrical supplies and accessories – Raamovereenkomst voor het leveren van verlichtingsarmaturen
Czechia – Vertical-spindle machining centre – Pořízení 5-osého CNC centra
Poland – Miscellaneous medical devices and products – Zakup i dostawa sprzętu i wyposażenia dla Zakładu Opiekuńczo-Leczniczego
Sweden – Water plumbing work – Ramavtal för entreprenader för schaktfri ledningsrenovering med flexibla foder
Poland – Miscellaneous evaluation or testing instruments – Zakup i dostawa do laboratoriów GIOŚ wyposażenia do zatężania ekstraktów chromatograficznych
Opportunity Score
Why this score?
Opportunity
0 / 100
Complexity
0 / 100
Deep Portfolio Analysis
Uses:
- Description
- Industries & Services
- Capabilities
- Market & Experience
- Certifications